Cloud Computing is fastest growing segment fueling the growth of U.S. Contract Research Organization (CROs) Market
The global U.S. Contract Research Organization (CROs) Market is estimated to be valued at US$ 17446.79 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The U.S. Contract Research Organization (CROs) Market comprises companies that
provide support to the pharmaceutical, biotechnology, medical device and
government/regulatory sectors for clinical trials. CROs provide various
services starting from study design, data analysis to regulatory consultations.
They help organizations focus on their core competencies by outsourcing
additional capabilities.
Market key trends:
The growing demand for outsourcing clinical trials and increasing research and
development activities in the pharmaceutical and biotechnology industries drive
the growth of the U.S. CRO market. Moreover, increasing adoption of cloud-based
technologies by CROs is also fueling market growth. Cloud offers scalability,
security and cost benefits which is attracting many small as well as large CROs
to adopt cloud platforms for conducting clinical trials. It has streamlined
clinical trial processes and improved connectivity between research sites and
sponsors. This has significantly increased efficiency while reducing costs.
Advanced cloud technologies are thus expected to open new opportunities for
CROs in the coming years.
Segment Analysis
The U.S.
Contract Research Organization (CROs) market size is segmented based on
services, therapeutic area and end user. By services, the clinical trial
services segment dominates the market owing to increasing research activities
in pharmaceutical and biotechnology industries. Clinical trial services help
sponsors to conduct research studies according to global regulatory standards.
By therapeutic area, oncology dominates owing to high disease prevalence and
increasing R&D activities for developing novel oncology drugs. By end user,
pharmaceutical and biotechnology companies hold the largest share as they
outsource their clinical trial activities to CROs to manage operations
efficiently.
Key Takeaways
The global U.S. Contract Research Organization (CROs) market is expected to
witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to
increasing R&D expenditure in pharmaceutical and biotechnology industries.
Regional analysis
North America dominates the CRO market owing to presence of many pharmaceutical
companies and favorable regulations for clinical trials. The U.S. holds the
highest share within North America due to increasing adoption of outsourcing
clinical trial activities. Asia Pacific exhibits the fastest growth due to low
cost of operations and growing clinical trial activity in China, India and
Japan.
Key players
Key players operating in the U.S. Contract Research Organization (CROs) market
are Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel
International Corporation, Syneos Health, PRA Health Sciences, Charles River
Laboratoires International Inc. (CRL), Pharmaceutical Product Development
(PPD), ICON Public Limited Corporation, Wuxi Apptec, Medpace Holdings, Inc,
Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, and
Clinipace. These players are focusing on new service launches and partnerships
with pharmaceutical companies to gain more market share.
Get
more insights on this topic: https://www.newsstatix.com/u-s-contract-research-organization-cros-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment